Brodsky AS, Fischer A, Miller DH, Vang S, MacLaughlan S, Wu H-T, Yu J, Steinhoff M, Collins C, Smith PJS, Raphael BJ, Brard L. Expression Profiling of Primary and Metastatic Ovarian Tumors Reveals Differences Indicative of Aggressive Disease. PLoS One. 2014; 9(4):e94476. doi:10.1371/journal.pone.0094476. PMID:24732363.

Ayyagari V, Brard L*. Bithionol Inhibits Ovarian Cancer Cell Growth In Vitro - Studies on Mechanism(s) of Action. BMC Cancer. 2014;14(1):61. doi:10.1186/1471-2407-14-61. PMID:24495391.

Kawar N, Maclaughlan S, Horan TC, Uzun A, Lange TS, Kim KK, Hopson R, Singh AP, Sidhu PS, Glass KA, Shaw S, Padbury JF, Vorsa N, Arnold LA, Moore RG, Brard L, Singh RK. PT19c, Another Nonhypercalcemic Vitamin D2 Derivative, Demonstrates Antitumor Efficacy in Epithelial Ovarian and Endometrial Cancer Models. Genes Cancer. 2013;4(11-12):524-534. doi:10.1177/1947601913507575. PMID:24386512

Vang S, Wu HT, Fischer A, Miller DH, Maclaughlan S, Douglass E, Steinhoff M, Collins C, Smith PJ, Brard L, Brodsky AS. Identification of Ovarian Cancer Metastatic miRNAs. PLoS One. 2013;8(3):e58226. doi:10.1371/journal.pone.0058226. PMID:23554878.

Horowitz NS, Olawaiye AB, Borger DR, Growdon WB, Krasner CN, Matulonis UA, Liu JF, Lee J, Brard L, Dizon DS. Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva. Gynecol Oncol. 2012;127(1):141-146. doi:10.1016/j.ygyno.2012.06.028. Epub 2012 Jun 26. PMID:22750258.

Kristjansdottir K, Kim K, Choi JS, Horan TC, Brard L, Moore RG, Singh RK. 7-Methyl Indole Ethyl Isothiocyanate causes ROS mediated apoptosis and cell cycle arrest in endometrial cancer cells. Gynecol Oncol. 2012;126(2):252-8. doi:10.1016/j.ygyno.2012.04.041. PMID:22561404.

Moore RG, Lange TS, Robinson K, Kim KK, Uzun A, Horan TC, Kawar N, Yano N, Chu SR, Mao Q, Brard L, Depaepe ME, Padbury JF, Arnold LA, Brodsky A, Shen TL, Singh RK. Efficacy of a Non-Hypercalcemic Vitamin-D2 Derived Anti-Cancer Agent (MT19c) and Inhibition of Fatty Acid Synthesis in an Ovarian Cancer Xenograft Model. PLoS One. 2012;7(4):e34443. doi:10.1371/journal.pone.0034443. PMID:22509304.

Kim KK, Lange TS, Singh RK, Brard L, Moore RG. Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C. BMC Cancer. 2012;12(1):147. PMID:22502731.

Yoshioka S, King ML, Ran S, Okuda H, MacLean II JA, McAsey ME, Sugino N, Brard L, Watabe K, Hayashi K. WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathway. Mol Cancer Res. 2012;10(3):469-482. doi:10.1158/1541-7786.MCR-11-0177.PMID:22232518. This paper was one of the most highly-cited (top five) Molecular Cancer Research articles published in 2012.

Kim KK, Singh AP, Singh RK, DeMartino A, Brard L, Vorsa N, Lange TS, Moore RG. Anti-angiogenic activity of cranberry proanthocyanidins and cytotoxic properties in ovarian cancer cells. Int J Oncol. 40(1):227-235 (2012). doi:10.3892/ijo.2011.1198. PMID:21922132.